Alexandru Calin Grigorescu. Tirosine Kinase Inhibitors (TKI) Used in the Treatment of Non-Small Cell Lung Cancer (NSCLC) Based on Specific Genetic Alterations. MSTI-V4 [Internet]. 2025 Feb. 4 [cited 2026 Jun. 4];:86-93. Available from: https://stm.bookpi.org/MSTI-V4/article/view/17124